SMTL ID : 8tze.1

Structure of C-terminal half of LRRK2 bound to GZD-824

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

monomer

Ligands

1 x T3X: 4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-[(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide(Non-covalent)

T3X.1: 23 residues within 4Å: Chain A: L.1885, F.1890, A.1904, K.1906, E.1920, V.1923, L.1924, L.1927, L.1932, I.1933, M.1947, E.1948, L.1949, A.1950, G.1953, L.1985, I.1990, I.1991, Y.1992, L.2001, I.2015, A.2016, D.2017 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:L.1885, A:A.1904, A:K.1906, A:K.1906, A:V.1923, A:L.1924, A:I.1933, A:L.2001, A:L.2001 Hydrogen bonds: A:E.1920, A:E.1920, A:A.1950, A:A.1950, A:D.2017 Salt bridges: A:D.2017, A:D.2017 pi-Stacking: A:F.1890 Halogen bonds: A:I.2015

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sanz Murillo, M. et al., Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures. Sci Adv (2023)

Release Date

2023-12-06

Peptides

Leucine-rich repeat serine/threonine-protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Leucine-rich repeat serine/threonine-protein kinase 2

Related Entries With Identical Sequence